Austar Lifesciences Limited Stock
Equities
6118
KYG0632L1023
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 HKD | -2.74% | -6.58% | -54.49% |
Mar. 26 | Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 22 | Austar Lifesciences to Swing to Loss; Shares Drop | MT |
Sales 2021 | 2.02B 280M 2.19B | Sales 2022 | 2.23B 309M 2.42B | Capitalization | 914M 127M 992M |
---|---|---|---|---|---|
Net income 2021 | 277M 38.43M 300M | Net income 2022 | 87M 12.07M 94.37M | EV / Sales 2021 | 3.09 x |
Net cash position 2021 | 64.52M 8.95M 69.99M | Net Debt 2022 | 188M 26.14M 204M | EV / Sales 2022 | 0.49 x |
P/E ratio 2021 |
22.8
x | P/E ratio 2022 |
10.5
x | Employees | 1,610 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 26.46% |
1 day | -2.74% | ||
1 week | -6.58% | ||
Current month | -6.58% | ||
1 month | -41.32% | ||
3 months | -56.97% | ||
6 months | -71.02% | ||
Current year | -54.49% |
Managers | Title | Age | Since |
---|---|---|---|
Kwok Keung Ho
CEO | Chief Executive Officer | 61 | 14-01-08 |
Yuk Kiu Mak
SEC | Corporate Secretary | - | 22-09-30 |
Xiang Di Tang
PRN | Corporate Officer/Principal | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Lap Kei Cheung
BRD | Director/Board Member | 52 | 14-10-20 |
Oi Kin Leung
BRD | Director/Board Member | 50 | 17-10-20 |
Kwok Keung Ho
CEO | Chief Executive Officer | 61 | 14-01-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.71 | -2.74% | 658,000 |
24-05-03 | 0.73 | -3.95% | 677,000 |
24-05-02 | 0.76 | 0.00% | 198,240 |
24-04-30 | 0.76 | 0.00% | 509,382 |
Delayed Quote Hong Kong S.E., May 06, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-54.49% | 47.9M | |
-4.02% | 184B | |
-0.75% | 108B | |
-2.97% | 67.82B | |
+4.48% | 51.05B | |
+9.09% | 44.67B | |
+3.40% | 41.78B | |
+3.12% | 26.78B | |
+4.10% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- 6118 Stock